44
Views
5
CrossRef citations to date
0
Altmetric
Review

Role of echocardiography in the contemporary management of chronic heart failure

, , &
Pages 51-70 | Published online: 10 Jan 2014

References

  • MacIntyre K, Capewell S, Stewart S, Chalmers JWT. Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation102, 1126–1131 (2000).
  • Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study Subjects. Circulation88, 107–115 (1993).
  • Doughty R, Yee T, Sharpe N, MacMahon S. Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988–1991. NZ Med. J.108, 473–475 (1995).
  • Koelling TM, Chen RS, Lubwama RN, L’Italien GJ, Eagle KA. The expanding national burden of heart failure and the United States: the influence of heart failure and women. Am. Heart J.147, 74–78 (2004).
  • Cowie MR, Wood DA, Coats AJS et al. Incidence and etiology of heart failure; a population-based study. Eur. Heart J.20(6), 421–428 (1999).
  • Braunwald E. Heart disease. In: A Textbook of Cardiovascular Medicine, Third Edition. WB Saunders, NY, USA (1988).
  • Cheesman M, Leech G, Chambers J, Monaghan M, Nihoyannopoulos P. Central role of echocardiography in the diagnosis and assessment of heart failure. Heart80(Suppl. 1), S1–S5 (1998).
  • Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) developed in collaboration with the International Society for Heart and Lung Transplantation endorsed by the Heart Failure Society of America. J. Am. Coll. Cardiol.38(7), 2101–2113 (2001).
  • Remme WJ, Swedberg K. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure: task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur. J. Heart Fail.4(1), 11–22 (2002).
  • Colquhoun MC, Waine C, Monaghan MJ, Struthers AD, Mills PG. Investigation in general practice of patients with suspected heart failure. Br. Heart J.74, 335–336 (1995).
  • Schiller NB, Shah PM, Crawford M et al. American Society of Echocardiography Committee on Standards on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J. Am. Soc. Echocardiogr.2, 358–367 (1989).
  • Devereux RB, Lutas EM, Casale PN et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J. Am. Coll. Cardiol.4(6), 1222–1230 (1984).
  • Ohno M, Cheng C-P, Little W. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation89, 2241–2250 (1994).
  • Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am. J. Cardiol.84(7), 829–832 (1999).
  • Gutman J, Wang Y, Wahr D, Schiller NB. Normal left atrial function determined by 2-dimensional echocardiography. Am. J. Cardiol.51(2), 336–340 (1983).
  • Appleton CP, Galloway JM, Gonzales MS, Gaball M, Basnight MA. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. J. Am. Coll. Cardiol.22, 1972–1982 (1993).
  • Tsang TSM, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am. J. Cardiol.90(12), 1284–1289 (2002).
  • Stefanadis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur. Heart J.22(1), 22–36 (2001).
  • Marwick TH. Techniques for comprehensive two-dimensional echocardiographic assessment of left ventricular systolic function. Heart89(Suppl. III), 2–8 (2003).
  • Amico A, Lichtenberg G, Reisner S, CK S, Schwartz R, Meltzer R. Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am. Heart J.118, 1259–1265 (1989).
  • Silcocks P, Munro J, Steeds R, Channer K. Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography. Heart78(3), 237–242 (1997).
  • Bansal S, Vacek J, Ehler D. Consistency of echocardiographic ejection fraction: variation and ‘drift’ by interpreter and practice site. Eur. J. Echocardiogr.3, 44–46 (2002).
  • Cerqueira M, Weissman NJ, Dilsizian V et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee on the council on clinical cardiology of the American Heart Association. Circulation105, 539–542 (2002).
  • Galasko GI, Basu S, Lahiri A, Senior R. A prospective comparison of echocardiographic wall-motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction. Heart86(3), 271–276 (2001).
  • McGowan JH, Martin W, Burgess MI et al. Validation of an echocardiographic wall motion index in heart failure due to ischemic heart disease. Eur. J. Heart Fail.3(6), 731–737 (2001).
  • Doughty RN, Whalley GA, Gamble GD, MacMahon S, Sharpe N. Effect of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. J. Card. Fail.6(1), 11–18 (2000).
  • Whalley GA, Gamble GD, Walsh HJ, Sharpe N, Doughty RN. Quantitative evaluation of regional endocardial visualization with second harmonic imaging and contrast left ventricular opacification in heart failure patients. Eur. J. Echocardiogr. (2004) (In Press).
  • McGowan J, Cleland J. The reliability of reporting left ventricular systolic function by echocardiography: a systematic review of three methods. Am. Heart J.146, 388–397 (2003).
  • Whalley G, Gamble G, Walsh H et al. Effect of tissue harmonic imaging and contrast between observer and test-retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure. Eur. J. Heart Fail.6, 85–93 (2004).
  • Caidahl K, Kazzam E, Lidberg J et al. New concept in echocardiography: harmonic imaging of tissue without use of contrast agent. Lancet352(9136), 1264–1270 (1998).
  • Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J. Am. Coll. Cardiol.32(5), 1426–1432 (1998).
  • Thomson HL, Basmadjian AJ, Rainbird AJ et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J. Am. Coll. Cardiol.38(3), 867–875 (2001).
  • Jenkins C, Bricknell K, Henekom L, Marwick T. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J. Am. Coll. Cardiol.44(4), 878–886 (2004).
  • Feigenbaum H, Zaky A, Nasser W. Use of echocardiography to measure left ventricular stroke volume. Circulation38, 1092–2099 (1967).
  • Pai RG, Bodenheimer MM, Pai SM, Koss JH, Adamick RD. Usefulness of systolic excursion of the mitral annulus as an index of left ventricular systolic function. Am. J. Cardiol.67(2), 222–224 (1991).
  • Willenheimer R, Israelsson B, Cline C, Rydberg E, Broms K, Erhardt L. Left atrioventricular plane displacement is related to both systolic and diastolic left ventricular performance in patients with chronic heart failure. Eur. Heart J.20(8), 612–618 (1999).
  • Bruch C, Gradaus R, Gunia S, Breithardt G, Wichter T. Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure. J. Am. Soc. Echocardiogr.16(10), 1031–1036 (2003).
  • Lang RM, Vignon P, Weinert L et al. Echocardiographic quantification of regional left ventricular wall motion with color kinesis. Circulation93(10), 1877–1885 (1996).
  • Chan J, Wahi S, Marwick TH. Anatomical M-mode: a novel technique for the quantitative evaluation of regional wall motion analysis during stress echocardiography. Int. J. Card. Imaging16, 247–255 (2002).
  • Gorscan J. Tissue Doppler echocardiography. Curr. Opin. Cardiol.15, 323–329 (2000).
  • Bargiggia G, Bertucci C, Recusani F et al. A new method for estimating left ventricular dP/dT by continuous wave Doppler-echocardiography. Validation studies at cardiac catheterization. Circulation80(5), 1287–1292 (1989).
  • Chen C, Rodriguez L, Levine R, Weyman A, Thomas J. Noninvasive measurement of the time constant of left ventricular relaxation using the continuous-wave Doppler velocity profile of mitral regurgitation. Circulation86(1), 271–278 (1992).
  • Armstrong W, Pellikka PA, Ryan T, Crouse L, Zoghbi WA. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. J. Am. Soc. Echocardiogr.11, 97–104 (1998).
  • Sawada S, Bapat A, Vaz D et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascularized patients with left ventricular dysfunction. J. Am. Coll. Cardiol.42(12), 2009–2015 (2003).
  • Liao L, Cabell CH, Jollis JG et al. Usefulness of myocardial viability or ischemia in predicting long-term survival of patients with severe left ventricular dysfunction undergoing revascularization. Am. J. Cardiol.93, 1275–1279 (2004).
  • Franchini M, Traversi E, Cannizzaro G, Cobelli F, Pozzoli M. Dobutamine stress echocardiography and thallium-201 SPECT for detecting ischemic dilated cardiomyopathy in patients with heart failure. Eur. J. Echocardiogr.1(2), 109–115 (2000).
  • Ramahi TM, Longo MD, Cadariu AR et al. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischemic cardiomyopathy. Eur. Heart J.22(10), 849–856 (2001).
  • Pratali L, Picano E, Otasevic P et al. Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am. J. Cardiol.88(12), 1374–1378 (2001).
  • Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Eur. Heart J.21(11), 927–934 (2000).
  • Naqvi TZ, Goel RK, Forrester JS, Siegel RJ. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent-onset idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol.34(5), 1537–1544 (1999).
  • Pinamonti B, Perkan A, Di Lenarda A, Gregori D, Sinagra G. Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur. J. Heart Fail.4(1), 49–61 (2002).
  • Ommen SR, Nishimura RA. A clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: update 2003. Heart89(Suppl. III), 18–23 (2003).
  • Nishimura R, Housmans PR, Hatle LK, Tajik AJ. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography, part 1: physiologic and pathophysiologic features. Mayo Clin. Proc.64, 71–81 (1989).
  • Cohen GI, Pietrolungo JF, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J. Am. Coll. Cardiol.27(7), 1753–1760 (1996).
  • Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta stone. J. Am. Coll. Cardiol.30(1), 8–18 (1997).
  • Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J. Am. Soc. Echocardiogr.10(3), 246–270 (1997).
  • Nishimura RA, Abel MD, Hatle LK, Tajik AJ. Relation of pulmonary vein to mitral flow velocities by transesophageal Doppler echocardiography: effect of different loading conditions. Circulation81, 1488–1497 (1990).
  • Kuecherer HF, Kusumoto F, Muhiudeen IA, Cahalan MK, Schiller NB. Pulmonary venous flow patterns by transesophageal pulsed Doppler echocardiography: relation to parameters of left ventricular systolic and diastolic function. Am. Heart J.122, 1683–1693 (1991).
  • Yamamoto K, Nishimura RA, Chalki HP, Appleton CP, Holmes DR, Redfield MM. Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: critical role of left ventricular systolic function. J. Am. Coll. Cardiol.30, 1819–1826 (1997).
  • Poerner TC, Goebel B, Unglaub P et al. Noninvasive evaluation of left ventricular filling pressures in patients with abnormal relaxation. Clin. Sci.106, 485–494 (2004).
  • Choong CY, Abascal VM, Thomas JD, Guerrero JL. Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. J. Am. Coll. Cardiol.10, 800–808 (1987).
  • Dumesnil JG, Gaudreault G, Honos GN, Kingma JG Jr. Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am. J. Cardiol.68(5), 515–519 (1991).
  • Pozzoli M, Traversi E, Cioffi G, Stenner R, Sanarico M, Tavazzi L. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation95, 1222–1230 (1997).
  • Brunner-LaRocca HP, Rickli H, Jost CHA, Jenni R. Left ventricular end-diastolic pressure can be estimated by either changes in transmitral inflow pattern during Valsalva maneuver or analysis of pulmonary venous flow. J. Am. Soc. Echocardiogr.13, 599–607 (2000).
  • Schwammenthal E, Popescu BA, Popescu AC et al. Association of left ventricular filling parameters assessed by pulsed wave Doppler and color M-mode Doppler echocardiography with left ventricular pathology, pulmonary congestion, and left ventricular end-diastolic pressure. Am. J. Cardiol.94(4), 488–491 (2004).
  • Firstenberg M, Levine B, Garcia MJ et al. Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers. J. Am. Coll. Cardiol.36, 1664–1669 (2000).
  • Moller JE, Sondergaard E, Poulsen SH, Seward JB, Appleton CP, Egstrup K. Color M-mode and pulsed wave tissue Doppler echocardiography: powerful predictors of cardiac events after first myocardial infarction. J. Am. Soc. Echocardiogr.14(8), 757–763 (2001).
  • Appleton CP, Jensen JL, Hatle LK, Oh JK. Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining flow velocity recordings. J. Am. Soc. Echocardiogr.10, 271–291 (1997).
  • Nagueh S, Middleton K, Koplen H. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of left ventricular filling pressures. J. Am. Coll. Cardiol.30, 1527–1533 (1997).
  • Ommen SR, Nishimura RA, Appleton CP et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. A comparative simultaneous Doppler-catheterization study. Circulation102, 1788–1794 (2000).
  • Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue Doppler imaging. Circulation98(16), 1644–1650 (1998).
  • Hofmann T, Keck A, van Ingen G, Simic O, Ostermeyer J, Meinertz T. Simultaneous measurement of pulmonary venous flow by intravenous catheter Doppler velocimetry and transesophageal Doppler echocardiography: relation to left atrial pressure and left atrial and left ventricular function. J. Am. Coll. Cardiol.26, 239–249 (1995).
  • Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes DR Jr, Tajik AJ. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J. Am. Coll. Cardiol.28(5), 1226–1233 (1996).
  • Kuecherer H, Muhiudeen I, Kusumoto F et al. Estimation of mean left atrial pressure from transesophageal pulsed wave Doppler echocardiography of pulmonary venous flow. Circulation82, 1127–1139 (1990).
  • Pozzoli M, Capomolla S, Pinna G, Cobelli F, Tavazzi L. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J. Am. Coll. Cardiol.27, 883–893 (1996).
  • Nagueh SF, Kopelen H, Quinones M. Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation. Circulation94, 2138–2145 (1996).
  • Chirrillo F, Brunazzi M, Barbiero M et al. Estimating mean pulmonary wedge pressure in patients with chronic atrial fibrillation from transthoracic Doppler indices of mitral and pulmonary venous flow velocity. J. Am. Coll. Cardiol.30, 19–26 (1997).
  • Temporelli P, Scapellato F, Corrà U, Eleuteri E, Imparato A, Giannuzzi P. Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am. J. Cardiol.83, 724–727 (1999).
  • Garcia M, Smedira N, Greenberg N et al. Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: animals and human validation. J. Am. Coll. Cardiol.35, 201–208 (2000).
  • Traversi E, Cobelli F, Pozzoli M. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure even when atrial fibrillation is present. Eur. J. Heart Fail.3, 173–181 (2001).
  • Yamamoto T, Oki T, Yamada H et al. Prognostic value of the atrial systolic mitral annular motion velocity in patients with left ventricular systolic dysfunction. J. Am. Soc. Echocardiogr.16, 333–339 (2003).
  • Dokainish H, Zoghbi WA, Lakkis N et al. Optimal noninvasive assessment of left ventricular filling pressures. A comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation109, 2432–2439 (2004).
  • Little W, Ohno M, Kitzman D, Thomas J, Cheng C. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation92, 1933–1939 (1995).
  • Margulies KB, Jaffer S, Pollack PS, Ennis KJ. Physiological significance of early deceleration time prolongation in asymptomatic elderly subjects. J. Card. Fail.5(2), 92–99 (1999).
  • Rossvoll O, Hatle LK. Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J. Am. Coll. Cardiol.21(7), 1687–1696 (1993).
  • Gheorghiade M, Bonow RO. Chronic heart failure in the USA: a manifestation of coronary artery disease. Circulation97(3), 282–289 (1998).
  • Masoudi FA, Havranek EP, Smith G et al. Gender, age, and heart failure with preserved left ventricular systolic function. J. Am. Coll. Cardiol.41(2), 217–223 (2003).
  • Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J.22(17), 1527–1560 (2001).
  • European Study Group on Diastolic Heart Failure. European heart failure management guidelines: how to diagnose diastolic heart failure. Eur. Heart J.19(7), 990–1003 (1998).
  • Khunti K, Hearnshaw H, Baker R, Grimshaw G. Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur. J. Heart Fail.4(6), 771–777 (2002).
  • Rutten FH, Grobbee DE, Hoes AW. Diagnosis and management of heart failure: a questionnaire general practitioners and cardiologists. Eur. J. Heart Fail.5, 345–348 (2003).
  • Senni M, Rodeheffer RJ, Tribouilloy CM et al. Use of echocardiography in the management of congestive heart failure in the community. J. Am. Coll. Cardiol.33(1), 164–170 (1999).
  • Khunti K. Systematic review of open access echocardiography for primary care. Eur. J. Heart Fail.6(1), 79–83 (2004).
  • Whalley G, Doughty R, Gamble G et al. Pseudonormal mitral filling pattern predicts hospital re-admission in patients with chronic congestive heart failure. J. Am. Coll. Cardiol.39, 1878–1895 (2002).
  • Varadarajan P, Pai R. Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2258 hospitalized patients. J. Card. Fail.9(2), 107–112 (2003).
  • Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJV. More malignant than cancer? 5-year survival following a first admission for heart failure. Eur. J. Heart Fail.3, 315–322 (2001).
  • Gradman A, Deedwania P, Cody R et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril–Digoxin Study Group. J. Am. Coll. Cardiol.14(3), 564–570 (1989).
  • Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am. J. Cardiol.62, A25–A30 (1988).
  • van den Broek SA, van Veldheisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. Comparison between New York Heart Association classification in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic cardiomyopathy. Am. J. Cardiol.70(3), 359–363 (1992).
  • White H, Norris R, Brown M, Brandt P, Whitlock R, Wild C. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation76, 44–51 (1987).
  • Curtis J, Sokol S, Wang Y et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J. Am. Coll. Cardiol.42, 736–742 (2003).
  • Wong M, Staszewsky L, Latini R et al. Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure. Valsartan in Heart Failure Trial (Val–HeFT) echocardiographic data. J. Am. Coll. Cardiol.43(11), 2022–2027 (2004).
  • Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of moderate renal insufficiency in asymptomatic patients with left ventricular systolic dysfunction. J. Am. Coll. Cardiol.35(3), 681–689 (2000).
  • Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J. Am. Coll. Cardiol.22, 808–815 (1993).
  • Xie GY, Berk MR, Smith MD, Gurley JC, DeMaria AN. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J. Am. Coll. Cardiol.24, 132–139 (1994).
  • Werner GS, Schaefer C, Dirks R, Figulla HR, Kreuzer H. Prognostic value of Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy. Am. J. Cardiol.73(11), 792–798 (1994).
  • Pozzoli M, Capomolla S, Sanarico M, Pinna G, Cobelli F, Tavazzi L. Doppler evaluations of left ventricular diastolic filling and pulmonary wedge pressure provide similar prognostic information in patients with systolic impairment. Am. Heart J.129, 716–725 (1995).
  • Giannuzzi P, Temporelli PL, Bosmini E et al. Independent and incremental prognostic value of Doppler-derived mitral decleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J. Am. Coll. Cardiol.28, 383–390 (1996).
  • Nijland F, Kamp O, Karreman AJ, van Eenige MJ, Visser CA. Prognostic implications of restrictive left ventricular filling in acute myocardial infarction: a serial Doppler echocardiographic study. J. Am. Coll. Cardiol.30(7), 1618–1624 (1997).
  • Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sinagra G, Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J. Am. Coll. Cardiol.29, 604–612 (1997).
  • Tabet J-Y, Logeart D, Geyer C et al. Comparison of the prognostic value of left ventricular filling and peak oxygen uptake in patients with systolic heart failure. Eur. Heart J.21(22), 1864–1871 (2000).
  • Rich M, Stitziel N, Kovacs S. Prognostic value of diastolic filling parameters derived using a novel image processing technique in patients ≥70 years of age with congestive heart failure. Am. J. Cardiol.84, 82–86 (1999).
  • Møller JE, Søndergaard E, Poulsen SH, Egstrup K. Pseudonormal and restrictive filling patterns predict left ventricular dilatation and cardiac death after a first myocardial inrfarction: a serial color M-mode Doppler echocardiographic study. J. Am. Coll. Cardiol.36, 1841–1846 (2000).
  • Dini FL, Michelassi C, Micheli G, Rovai D. Prognostic value of pulmonary venous flow Doppler signal in left ventricular dysfunction. J. Am. Coll. Cardiol.36, 1295–1302 (2000).
  • Hansen A, Haass M, Zugck C et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with congestive heart failure. J. Am. Coll. Cardiol.37, 1049–1055 (2001).
  • Yong Y, Nagueh SF, Shimoni S et al. Deceleration time in ischemic cardiomyopathy. Relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization. Circulation103, 1232–1237 (2001).
  • Morales FJ, Asencio MC, Oneto J et al. Deceleration time of early filling in patients with left ventricular systolic dysfunction: functional and prognostic independent value. Am. Heart J.143, 1101–1106 (2002).
  • Faris R, Coats A, Henein M. Echocardiography-derived variables predict outcome in patients with non-ischemic dilated cardiomyopathy with or without a restrictive filling pattern. Am. Heart J.144, 343–350 (2002).
  • Wang M, Yip G, Wang A et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J. Am. Coll. Cardiol.41, 820–826 (2003).
  • Hillis G, Møller JE, Pellikka PA et al. Noninvasive estimation of left ventricular filling pressure by E/e´ is a powerful predictor of survival after acute myocardial infarction. J. Am. Coll. Cardiol.43, 360–367 (2004).
  • Hurrell D, Oh J, Mahoney D, Miller F, Seward J. Short deceleration time of mitral inflow E velocity: prognostic implication with atrial fibrillation. J. Am. Soc. Echocardiogr.11, 450–457 (1998).
  • Bettencourt P, Ferreira A, Dias P et al. Predictors of prognosis in patients with stable mild to moderate heart failure. J. Card. Fail.6(4), 306–313 (2000).
  • Temporelli PL, Corra U, Imparato A, Bosimini E, Scapellato F, Giannuzzi P. Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic heart failure. J. Am. Coll. Cardiol.31(7), 1591–1597 (1998).
  • Temporelli PL, Giannuzzi P, Nicolosi GL et al. Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 Echo substudy. J. Am. Coll. Cardiol.43(9), 1646–1653 (2004).
  • Liu J, Tanaka N, Murata K et al. Prognostic value of pseudonormal and restrictive filling patterns on left ventricular remodeling and cardiac events after coronary artery bypass grafting. Am. J. Cardiol.91(5), 550–554 (2003).
  • Sabharwal N, Cemin R, Rajan K, Hickman M, Lahiri A, Senior R. Usefulness of left atrial volume as a predictor of mortality in patients with ischemic cardiomyopathy. Am. J. Cardiol.94(6), 760–763 (2004).
  • Florea V, Henein M, Cicoira M et al. Echocardiographic determinants of mortality in patients over 67 years of age with chronic heart failure. Am. J. Cardiol.86, 158–161 (2000).
  • Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure. Eur. Heart J.19(5), 696–710 (1998).
  • Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J. Am. Coll. Cardiol.33(7), 1948–1955 (1999).
  • Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J. Am. Coll. Cardiol.41(9), 1510–1518 (2003).
  • Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am. J. Cardiol.88, 530–533 (2001).
  • Willenheimer R, Cline C, Erhardt L, Israelsson B. Left ventricular atrioventricular plane displacement: an echocardiographic technique for rapid assessment of prognosis in heart failure. Heart7(3), 230–236 (1997).
  • Rydberg E, Erhardt L, Brand B, Willenheimer R. Left atrioventricular plane displacement determined by echocardiography: a clinically useful, independent predictor of mortality in patients with stable coronary artery disease. J. Intern. Med.254(5), 479–485 (2003).
  • Møller JE, Hillis GS, Oh JK et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation107(17), 2207–2212 (2003).
  • Møller JE, Egstrup K, Kober L, Poulsen SH, Nyvad O, Torp-Pedersen C. Prognostic importance of systolic and diastolic function after acute myocardial infarction. Am. Heart J.145, 147–153 (2003).
  • Beinart R, Boyko V, Schwammenthal E et al. Long-term prognostic significance of left atrial volume in acute myocardial infarction. J. Am. Coll. Cardiol.44(2), 327–334 (2004).
  • Capomolla S, Pinna G, Febo O et al. Echo-Doppler mitral flow monitoring: An operative tool to evaluate day-to-day tolerance to and effectiveness of β-adrenergic blocking agent therapy in patients with chronic heart failure. J. Am. Coll. Cardiol.38(6), 1675–1684 (2001).
  • Davies SW, Fussell AL, Jordan SL, Poole-Wilson PA, Lipkin DP. Abnormal diastolic filling patterns in chronic heart failure – relationship to exercise capacity. Eur. Heart J.13, 749–757 (1992).
  • Redfield MM, Jacobsen S, Burnett JC, Mahoney DW, Bailey K, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community. J. Am. Med. Assoc.289, 194–202 (2003).
  • Peltier M, Slama M, Garbi S, Enriquez-Sarano M, Goissen T, Tribouilloy CM. Prognostic value of Doppler-derived myocardial performance index in patients with left ventricular systolic dysfunction. Am. J. Cardiol.90, 1261–1263 (2002).
  • Gavazzi A, Berzuini C, Campana C et al. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J. Heart Lung Transpl.16(7), 774–785 (1997).
  • Karatasakis GT, Karagounis LA, Kalyvas PA et al. Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure. Am. J. Cardiol.82(3), 329–334 (1998).
  • Ghio S, Gavazzi A, Campana C et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J. Am. Coll. Cardiol.37(1), 183–188 (2001).
  • Ghio S, Recusani F, Klersy C et al. Prognostic usefulness of the triscupid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am. J. Cardiol.85(7), 837–842 (2000).
  • Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic failure. Am. Heart J.144, 524–529 (2002).
  • Trichon BH, Felker M, Shaw LK, Cabell CH, O’Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am. J. Cardiol.91, 538–543 (2003).
  • Cabell CH, Trichon BH, Velazquez EJ et al. Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized AmlodopIne Survival Evaluation (PRAISE-2) echocardiographic study. Am. Heart J.147, 151–157 (2004).
  • The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med.325, 293–302 (1991).
  • The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Co-Operative North Scandinavian ENalapril SUrvival Study (CONSENSUS). N. Engl. J. Med.316, 1429–1435 (1987).
  • Yusuf S, Pepine CJ, Garces C et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet340(8829), 1173–1178 (1992).
  • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med.327, 685–691 (1992).
  • Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N. Engl. J. Med.327, 669–677 (1992).
  • Kober L, Torp-Pedersen C, Carlsen JE et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. TRAndolapril Cardiac Evaluation (TRACE) Study Group. N. Engl. J. Med.333(25), 1670–1676 (1995).
  • Australia and New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol in patients with congestive heart failure due to ischemic heart disease: final results from the Australia–New Zealand Heart Failure Research Collaborative Group trial. Lancet349, 375–380 (1997).
  • Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med.341, 709–717 (1999).
  • The HOPE Study investigators. Effects of an angiotensin-converting enzyme inhibitor on cardiovascular events in high-risk patients. N. Engl. J. Med.342(3), 145–153 (2000).
  • Arnold J, Yusuf S, Young J et al. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation107, 1284–1290 (2003).
  • Gottdiener JS, McClelland RL, Marshall R et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann. Intern. Med.137(8), 631–639 (2002).
  • Yusuf S, Pfeffer MA, Swedberg K et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet362(9386), 777–781 (2003).
  • Moss A, Zareba W, Hall W et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med.346(12), 877–883 (2002).
  • Buxton A, Lee K, Fisher J et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N. Engl. J. Med.341(25), 1882–1890 (1999).
  • Bristow MR, Saxon LA, Boehmer J et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med.350(21), 2140–2150 (2004).
  • Yu C-M, Chau E, Sanderson JE et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation105(4), 438–445 (2002).
  • Sogaard P, Egeblad H, Pedersen AK et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation106(16), 2078–2084 (2002).
  • Bordacher P, Garrigue S, Lafitte S et al. Interventricular and intraventricular electromechnical delays in right ventricular paced patients with heart failure: implications for upgrading to biventricular stimulation. Heart89, 1401–1405 (2003).
  • Bader H, Garrique S, Lafitte S et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events and heart failure patients in. J. Am. Coll. Cardiol.1143(2), 248–256 (2004).
  • Oguz E, Dagdeviren B, Bilsel T et al. Echocardiographic prediction of long-term response to biventricular pacemaker in severe heart failure. Eur. J. Heart Fail.4(1), 83–90 (2002).
  • Sharpe N, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet8585, 255–259 (1988).
  • Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet337, 872–876 (1991).
  • Pfeffer M, Lamas G, Vaughan D, Parisi A, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N. Engl. J. Med.319(2), 80–86 (1988).
  • Gilbert EM, Anderson JL, Deitchman D et al. Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am. J. Med.88, 223–229 (1990).
  • Bristow M, Gilbert E, Abraham WT, Adams K, Fowler M, Hershberger RE. Carvedilol produces dose-related improvements in left ventricular function and survival in patients with chronic heart failure. Circulation94, 2807–2816 (1996).
  • Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia–New Zealand Heart Failure Research Collaborative Group. J. Am. Coll. Cardiol.29(5), 1060–1066 (1997).
  • MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet353, 2001–2007 (1999).
  • Doughty RN, Whalley GA, Walsh HJ, Gam D, Lopez-Sendon J, Sharpe N. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction. The CAPRICORN Echo Substudy. Circulation109, 201–206 (2004).
  • Hole T, Otterstad JE, St John Sutton M, Froland G, Holme I, Skjaerpe T. Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction. Eur. J. Echocardiogr.3(4), 263–270 (2002).
  • Palazzuoli A, Carrera A, Calabria P et al. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure. Am. Heart J.147(1), 73–79 (2004).
  • Traversi E, Pozzoli M, Cioffi G et al. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am. Heart J.132, 809–819 (1996).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.